IHCH-7179
Pharmaceutical compound
From Wikipedia, the free encyclopedia
IHCH-7179 is a serotonin and dopamine receptor modulator related to the ergolines and phenylpiperazines.[1][2] It acts as a serotonin 5-HT1A receptor agonist, serotonin 5-HT2A receptor antagonist, and dopamine D2 receptor partial agonist.[1] The drug produces antipsychotic-like effects in rodents, such as prevention of the hyperlocomotion induced by the NMDA receptor antagonist dizocilpine (MK-801).[1] It also blocks the head-twitch response induced by the serotonergic psychedelic LSD.[1] IHCH-7179 was first described in the scientific literature by 2024.[1] It was developed by the Chinese Academy of Sciences and associated organizations in Shanghai, China.[1][2] IHCH-7179 is of interest for potential treatment of schizophrenia.[1][2]
- None
 | |
| Clinical data | |
|---|---|
| Other names | IHCH7179 |
| Drug class | Serotonin 5-HT1A receptor agonist; Serotonin 5-HT2A receptor antagonist; Dopamine D2 receptor partial agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| PDB ligand | |
| Chemical and physical data | |
| Formula | C23H24FN3O |
| Molar mass | 377.463 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
